These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18203844)

  • 41. Involvement of opioid delta (delta)- and kappa (kappa)-receptors in ischemic preconditioning in a rat model of myocardial infarction.
    Valtchanova-Matchouganska A; Ojewole JA
    Methods Find Exp Clin Pharmacol; 2002 Apr; 24(3):139-44. PubMed ID: 12087875
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies.
    Devine DP; Leone P; Pocock D; Wise RA
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1236-46. PubMed ID: 7690399
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Opioid control of the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo.
    Collin E; Frechilla D; Pohl M; Bourgoin S; Le Bars D; Hamon M; Cesselin F
    Brain Res; 1993 Apr; 609(1-2):211-22. PubMed ID: 8389648
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiac μ-opioid receptor contributes to opioid-induced cardioprotection in chronic heart failure.
    He SF; Jin SY; Yang W; Pan YL; Huang J; Zhang SJ; Zhang L; Zhang Y
    Br J Anaesth; 2018 Jul; 121(1):26-37. PubMed ID: 29935580
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dual effects of DAMGO [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin and CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2) on adenylyl cyclase activity: implications for mu-opioid receptor Gs coupling.
    Szücs M; Boda K; Gintzler AR
    J Pharmacol Exp Ther; 2004 Jul; 310(1):256-62. PubMed ID: 14996951
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endogenous opioids upregulate brain-derived neurotrophic factor mRNA through delta- and micro-opioid receptors independent of antidepressant-like effects.
    Zhang H; Torregrossa MM; Jutkiewicz EM; Shi YG; Rice KC; Woods JH; Watson SJ; Ko MC
    Eur J Neurosci; 2006 Feb; 23(4):984-94. PubMed ID: 16519663
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Delta-opioid ligands reverse alfentanil-induced respiratory depression but not antinociception.
    Su YF; McNutt RW; Chang KJ
    J Pharmacol Exp Ther; 1998 Dec; 287(3):815-23. PubMed ID: 9864259
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Opioid antagonists and antisera to endogenous opioids increase the nociceptive response to formalin: demonstration of an opioid kappa and delta inhibitory tone.
    Ossipov MH; Kovelowski CJ; Wheeler-Aceto H; Cowan A; Hunter JC; Lai J; Malan TP; Porreca F
    J Pharmacol Exp Ther; 1996 May; 277(2):784-8. PubMed ID: 8627559
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kappa- but not delta-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats.
    Wang GY; Wu S; Pei JM; Yu XC; Wong TM
    Am J Physiol Heart Circ Physiol; 2001 Jan; 280(1):H384-91. PubMed ID: 11123255
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ARD-353 [4-((2R,5S)-4-(R)-(4-diethylcarbamoylphenyl)(3-hydroxyphenyl)methyl)-2,5-dimethylpiperazin-1-ylmethyl)benzoic acid], a novel nonpeptide delta receptor agonist, reduces myocardial infarct size without central effects.
    Watson MJ; Holt JD; O'Neill SJ; Wei K; Pendergast W; Gross GJ; Gengo PJ; Chang KJ
    J Pharmacol Exp Ther; 2006 Jan; 316(1):423-30. PubMed ID: 16188952
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relative contribution of endogenous opioids to myocardial ischemic tolerance.
    Romano MA; Seymour EM; Berry JA; McNish RA; Bolling SF
    J Surg Res; 2004 May; 118(1):32-7. PubMed ID: 15093714
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Roles of endogenous opioid peptides in modulation of nocifensive response to formalin.
    Wu HE; Hung KC; Mizoguchi H; Nagase H; Tseng LF
    J Pharmacol Exp Ther; 2002 Feb; 300(2):647-54. PubMed ID: 11805228
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Involvement of the δ-opioid receptor in exercise-induced cardioprotection.
    Miller LE; McGinnis GR; Peters BA; Ballmann CG; Nanayakkara G; Amin R; Quindry JC
    Exp Physiol; 2015 Apr; 100(4):410-21. PubMed ID: 25639363
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ischemic preconditioning and morphine attenuate myocardial apoptosis and infarction after ischemia-reperfusion in rabbits: role of delta-opioid receptor.
    Okubo S; Tanabe Y; Takeda K; Kitayama M; Kanemitsu S; Kukreja RC; Takekoshi N
    Am J Physiol Heart Circ Physiol; 2004 Oct; 287(4):H1786-91. PubMed ID: 15231506
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of Endogenous Agonists of Opioid Receptors in the Regulation of Heart Resistance to Postischemic Reperfusion Injury.
    Gorbunov AS; Vaizova OE; Belousov MV; Pozdnyakova SV; Nesterov EA; Madonov PG
    Bull Exp Biol Med; 2017 Nov; 164(1):18-20. PubMed ID: 29119401
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ischemic preconditioning is mediated by a peripheral opioid receptor mechanism in the intact rat heart.
    Schultz JJ; Hsu AK; Gross GJ
    J Mol Cell Cardiol; 1997 May; 29(5):1355-62. PubMed ID: 9201621
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Receptor-selective antagonism of opioid antinociception in female versus male rats.
    Craft RM; Tseng AH; McNiel DM; Furness MS; Rice KC
    Behav Pharmacol; 2001 Dec; 12(8):591-602. PubMed ID: 11856896
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endogenous opioid peptides contribute to antinociceptive potency of intrathecal [Dmt1]DALDA.
    Szeto HH; Soong Y; Wu D; Qian X; Zhao GM
    J Pharmacol Exp Ther; 2003 May; 305(2):696-702. PubMed ID: 12606628
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activation of delta- and kappa-opioid receptors by opioid peptides protects cardiomyocytes via KATP channels.
    Cao Z; Liu L; Van Winkle DM
    Am J Physiol Heart Circ Physiol; 2003 Sep; 285(3):H1032-9. PubMed ID: 12730057
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blocking mu opioid receptors in the spinal cord prevents the analgesic action by subsequent systemic opioids.
    Chen SR; Pan HL
    Brain Res; 2006 Apr; 1081(1):119-25. PubMed ID: 16499888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.